Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
VPS13A Gene Choreoacanthocytosis Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Excellence & Patient Assurance:
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Executive Summary: Our laboratory offers comprehensive next-generation sequencing (NGS) of the VPS13A gene for definitive diagnosis of choreoacanthocytosis (ChAc), a rare neurodegenerative disorder. The test is performed under DHA license 1143 with strict adherence to UAE data protection and health information laws.
Test Overview & Methodology
The VPS13A Gene NGS Test provides definitive diagnosis of choreoacanthocytosis (ChAc), a rare neurodegenerative disorder. Our NGS platform offers full-coding-region coverage, outperforming targeted approaches in sensitivity and variant detection.
| Feature | Our NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Precision | 99.9% analytical sensitivity for SNVs, indels | Limited to known mutations; <70% sensitivity for novel variants |
| Method | Next-Generation Sequencing (Illuminaยฎ platform) | Single-gene capillary electrophoresis |
| Turnaround | 3โ4 Weeks | 4โ6 Weeks (if multiple exons tested) |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Genetics, I witness how genetic clarity transforms familiesโ journeys. This test unveils the molecular basis of choreoacanthocytosis, yet clinical correlation remains paramount. Our NGS platform ensures high diagnostic yield for this rare condition." โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration 9294403.
Advisory: General Safety Measures
Important: Do not discontinue prescribed medication without consulting your doctor. This genetic test is for diagnostic purposes only and should not replace clinical evaluation or emergency care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Testing asymptomatic minors without DHA-approved genetic counselling (as per Federal Decree-Law No. 4 of 2016 on Medical Liability and international ethical standards).
- Emergency: Sudden severe chorea, swallowing difficulty, aspiration pneumonia, or acute psychiatric crisis require immediate hospital assessment.
Patient FAQ & Clinical Guidance
1. What is VPS13A choreoacanthocytosis and why is this test recommended?
Snippet: VPS13A choreoacanthocytosis is a rare inherited neurological disorder causing chorea, acanthocytosis, and behavioral changes, diagnosed through comprehensive gene sequencing. Our NGS test detects disease-causing variants across the entire VPS13A gene, enabling precise diagnosis, management, and family risk assessment.
2. How is the test performed and what sample is required?
Snippet: The test requires a simple blood draw or DNA sample via our VIP mobile phlebotomy home collection service, using Next-Generation Sequencing technology. We accept whole blood, extracted DNA, or a drop of blood on an FTA card, collected by our trained phlebotomy team.
3. How long until I receive results and what will they include?
Snippet: Results are delivered in 3 to 4 weeks with a detailed clinical report, genetic counselling support, and guidance for family planning. The report includes variant interpretation, clinical correlation recommendations, and a pedigree analysis if pre-counselling was conducted.
UAE Regulatory & Data Privacy Adherence
- Data Protection: All genetic data are protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information: Compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient safety and consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accreditation: ISO 9001:2015 Certified โ Cert. No. INT/EGQ/2509DA/3139. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | VPS13A Gene Choreoacanthocytosis Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole blood (3โ5 mL in EDTA) or extracted DNA; VIP mobile phlebotomy available. |
| Methodology Used | Next-Generation Sequencing (NGS) โ Illuminaยฎ platform, full coding region coverage |
| ICD-10-CM Code | G24.5 (Chorea) |
| LOINC Code | 48834-2 (VPS13A gene sequencing) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific preparation required"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians